As we continue to push the boundaries of innovation in the pharmaceutical industry, the role of patient advocacy organizations in R&D has never been more important. Patient organizations bring invaluable perspectives that help shape clinical development programs, making them more effective and patient-centered. At #MerzTx, we're proud to put patients first: Their voices are not only heard, but they are also integral to our work, from the early stages of research to the final stages of development. Learn more about the patient organizations we work with: https://lnkd.in/dY48tpz7
Merz Therapeutics’ Post
More Relevant Posts
-
Last week, Adam Feuerstein of STAT+ highlighted the complex relationships between patient organizations and pharmaceutical companies. This story emphasizes the need for industry transparency, the independence of advocacy organizations, and the respect for patients contributing to research. Rx4good's Chief Patient Advocate and SVP, Heidi Schultz Adams, shares her insights on our blog. Read more here: https://shorturl.at/9USy7 and sign up for our Good4Patients newsletter to keep up with the latest.
To view or add a comment, sign in
-
🔬 Join Jumo Health for an upcoming webinar to discover how the pharmaceutical industry is enhancing trial accessibility and representation through increased clinical trial diversity. The webinar features a diverse panel, including a patient advocate, a community organizer, and representatives from leading pharmaceutical companies. They’ll share insights on how to engage local community leaders to build trust and enhance trial participation. Key topics include: 🔍 A case study on using grassroots methods to recruit African American women for lupus studies. 🔍 A video series that highlights the power of diverse patient voices in clinical trials. 🔗 Register Here: https://buff.ly/4ctIVGS 🌟Featured speakers: LaToya Bolds-Johnson PA-C, CAQ-EM Kevin Aniskovich Tony Wafford Gwenn Oakes Michele Falk #ClinicalTrials #ClinicalResearch #PatientRecruitment #ClinicalData #PatientDiversity #ClinicalTrialDiversity #DiversityAndInclusion #DiversityAndInclusionInClinicalTrials
To view or add a comment, sign in
-
Great upcoming health equity webinar. Take a look below and register if you can make it. It will be a good one.
🔬 Join Jumo Health for an upcoming webinar to discover how the pharmaceutical industry is enhancing trial accessibility and representation through increased clinical trial diversity. The webinar features a diverse panel, including a patient advocate, a community organizer, and representatives from leading pharmaceutical companies. They’ll share insights on how to engage local community leaders to build trust and enhance trial participation. Key topics include: 🔍 A case study on using grassroots methods to recruit African American women for lupus studies. 🔍 A video series that highlights the power of diverse patient voices in clinical trials. 🔗 Register Here: https://buff.ly/4ctIVGS 🌟Featured speakers: LaToya Bolds-Johnson PA-C, CAQ-EM Kevin Aniskovich Tony Wafford Gwenn Oakes Michele Falk #ClinicalTrials #ClinicalResearch #PatientRecruitment #ClinicalData #PatientDiversity #ClinicalTrialDiversity #DiversityAndInclusion #DiversityAndInclusionInClinicalTrials
To view or add a comment, sign in
-
Mega proud to be part of this wonderful initiative. If you are involved in a partnership between biopharmaceutical companies and patient organisations, there is still time to register to take part via the link below!! Partnerships can be in any of the following: 💗Communications 📢 Advocacy 🌐Market Access 🔬Clinical trials 🧪R&D #patientadvocacy #marketaccess #healthcarecommunications
The end is fast approaching! Just 1 day to go until registrations close for the Patient Partnership Index 2023. If you would like to showcase your involvement in a partnership between biopharmaceutical companies and patient organisations across communications, advocacy, market access, clinical trials, or R&D, register now to submit an entry. Entries can be led by either partner and will be judged against a bespoke metric developed in partnership with industry and patient organisations to award Gold, Silver or Finalist standards. Entries to the Index close at 23:55 on Friday 26th April, so register now to receive an entry form, and ensure your partnerships get the recognition they deserve. The registration form, alongside FAQs and insights from last year’s Index, can be found via the link in comments. If you have any questions or require further support to get your entry (or entries) in by Friday, please reach out to the PPI team at info@patientpartnershipindex.co.uk. #clinicaltrials #marketaccess #researchanddevelopment #patientadvocacy #healthcarecommunications
To view or add a comment, sign in
-
The end is fast approaching! Just 1 day to go until registrations close for the Patient Partnership Index 2023. If you would like to showcase your involvement in a partnership between biopharmaceutical companies and patient organisations across communications, advocacy, market access, clinical trials, or R&D, register now to submit an entry. Entries can be led by either partner and will be judged against a bespoke metric developed in partnership with industry and patient organisations to award Gold, Silver or Finalist standards. Entries to the Index close at 23:55 on Friday 26th April, so register now to receive an entry form, and ensure your partnerships get the recognition they deserve. The registration form, alongside FAQs and insights from last year’s Index, can be found via the link in comments. If you have any questions or require further support to get your entry (or entries) in by Friday, please reach out to the PPI team at info@patientpartnershipindex.co.uk. #clinicaltrials #marketaccess #researchanddevelopment #patientadvocacy #healthcarecommunications
To view or add a comment, sign in
-
🔍 The future of clinical trials is here! Alpha Sophia’s new blog post delves into how 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐬 (𝐂𝐑𝐎𝐬) can harness targeting data to swiftly identify the best clinicians and centers of excellence. 🎯 This data-driven approach not only speeds up trial processes but also boosts recruitment and outcomes by engaging with the right healthcare providers and Key Opinion Leaders (KOLs). 👩⚕️ 🚀 For CROs aiming to stay ahead in the pharmaceutical industry, this strategy is a game-changer. Read the the full boost in the comments below! 👇
To view or add a comment, sign in
-
Are you collaborating with patient organizations in Europe? If so, take the survey and become a valuable part of our research! 🌐 Healthcare Education Institute wants to explore the dynamics between the industry and patient organizations. We're reaching out to representatives on both sides to understand: 📌 Is there a common interest? 📌 How can we enhance collaboration? 📌 In what ways can the parties support each other? This survey is for all professionals in the pharmaceutical industry in Europe who are currently or have previously cooperated with patient organizations, directly or indirectly. It only takes 7 minutes – participate now: https://lnkd.in/dePWQvn7 We'll share the insightful results with our LinkedIn community in the form of a comprehensive report. Thank you for contributing! 📊 #PatientAdvocacy #Survey #PharmaceuticalIndustry #PatientOrganizations
To view or add a comment, sign in
-
In our latest video, we explore the partnership between pharmaceutical companies and patient advocacy groups. Discover how this collaboration amplifies patient voices and accelerates medical research. Click the link to check out our video! #PatientAdvocacy https://bit.ly/41RwEZf
To view or add a comment, sign in
-
The power of collaboration in healthcare cannot be overstated! Check out our article exploring the partnership between pharmaceutical companies and patient advocacy groups. This enhances patient outcomes and elevates the healthcare experience. #Pharma https://bit.ly/3tmPvP5
To view or add a comment, sign in
-
As we continue to expand access to clinical research within historically underrepresented communities, we have partnered with industry leaders to discuss how community-based research can improve medical advancement for the industry, physicians, and patients. We're introducing our new Community-Based Research Webinar Series with Part 1: Understanding This New Frontier of Sites and the Benefits For Your Clinical Trials. The first webinar in the series explores our Community Research Network and the impact of community healthcare on accelerating drug development and medical innovation. Hosted by our Senior Vice President of Commercial, Laura Warwick, with panelists Alaina Anderson, MBA (Sanofi) and Elizabeth Seyfert (Fortrea) this discussion will include: - The significance of community-based research in the pharmaceutical landscape - How community-based research sites differ from traditional models - Challenges and considerations for pharmaceutical sponsors and CROs - Factors to weigh when selecting a community research site Join us for an enlightening webinar series on enhancing participant representation in research through community-based clinical trials! Register here for Part 1: https://buff.ly/3uP4XEq #webinar #community #clinicalresearch
To view or add a comment, sign in
72,749 followers